Literature DB >> 19641502

BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention.

J Hutcheson1, H Perlman.   

Abstract

Rheumatoid arthritis (RA) is a debilitating disease, resulting in the destruction of bone and cartilage, and in the permanent disfigurement of joints. Although the precise cause of RA is currently unresolved, it has become clear that the damaging effects are a result of the toxic milieu caused by an influx of inflammatory cells and the resulting heightened proinflammatory state within the joint. As the amount of literature suggesting that this preponderance of cells is a result of decreased local apoptosis in the joint continues to increase, in this review, we describe how Bcl-2 family pro-apoptotic BH3-only proteins, particularly Bim and Bid, could act to protect against the development of the disease. We also suggest a role for BH3-mimetic drugs as potential therapeutics in the treatment of RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19641502      PMCID: PMC2838494          DOI: 10.1038/onc.2009.54

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  77 in total

1.  Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release.

Authors:  J Whitfield; S J Neame; L Paquet; O Bernard; J Ham
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

2.  Biochemistry and function of the DISC.

Authors:  H Walczak; M R Sprick
Journal:  Trends Biochem Sci       Date:  2001-07       Impact factor: 13.807

3.  The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells.

Authors:  L A O'Reilly; L Cullen; J Visvader; G J Lindeman; C Print; M L Bath; D C Huang; A Strasser
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

5.  Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis.

Authors:  G V Putcha; K L Moulder; J P Golden; P Bouillet; J A Adams; A Strasser; E M Johnson
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

6.  Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.

Authors:  P F Dijkers; R H Medema; J W Lammers; L Koenderman; P J Coffer
Journal:  Curr Biol       Date:  2000-10-05       Impact factor: 10.834

7.  Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis.

Authors:  Michela Marani; Tencho Tenev; David Hancock; Julian Downward; Nicholas R Lemoine
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis.

Authors:  H Perlman; L J Pagliari; H Liu; A E Koch; G K Haines; R M Pope
Journal:  Arthritis Rheum       Date:  2001-01

9.  Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis.

Authors:  M Harjacek; S Diaz-Cano; M De Miguel; H Wolfe; C A Maldonado; G A Rabinovich
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

10.  Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.

Authors:  V R Sutton; J E Davis; M Cancilla; R W Johnstone; A A Ruefli; K Sedelies; K A Browne; J A Trapani
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  16 in total

Review 1.  Noxa in rheumatic diseases: present understanding and future impact.

Authors:  Karissa E Cottier; Elise M Fogle; David A Fox; Salahuddin Ahmed
Journal:  Rheumatology (Oxford)       Date:  2013-12-17       Impact factor: 7.580

2.  Chondrocyte Apoptosis in Rheumatoid Arthritis: Is Preventive Therapy Possible?

Authors:  Charles J Malemud
Journal:  Immunotherapy (Los Angel)       Date:  2015-10-31

Review 3.  The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.

Authors:  FuNien Tsai; Harris Perlman; Carla M Cuda
Journal:  Clin Immunol       Date:  2016-10-22       Impact factor: 3.969

4.  Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis.

Authors:  Melissa Mavers; Carla M Cuda; Alexander V Misharin; Angelica K Gierut; Hemant Agrawal; Evan Weber; Deborah Veis Novack; G Kenneth Haines; Dimitrios Balomenos; Harris Perlman
Journal:  Arthritis Rheum       Date:  2012-01

5.  Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation.

Authors:  Carla M Cuda; Alexander V Misharin; Angelica K Gierut; Rana Saber; G Kenneth Haines; Jack Hutcheson; Stephen M Hedrick; Chandra Mohan; G Scott Budinger; Christian Stehlik; Harris Perlman
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

Review 6.  The discovery of novel experimental therapies for inflammatory arthritis.

Authors:  Charles J Malemud
Journal:  Mediators Inflamm       Date:  2010-03-18       Impact factor: 4.711

Review 7.  Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis.

Authors:  Bonnie Williams; Anak Dharmapatni; Tania Crotti
Journal:  Inflamm Res       Date:  2017-11-21       Impact factor: 4.575

Review 8.  The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases.

Authors:  Carla M Cuda; Richard M Pope; Harris Perlman
Journal:  Nat Rev Rheumatol       Date:  2016-08-23       Impact factor: 20.543

Review 9.  Regulation of antiviral CD8 T-cell responses.

Authors:  Joseph M Kulinski; Vera L Tarakanova; James Verbsky
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

10.  Induction of apoptosis by fucoidan in human leukemia U937 cells through activation of p38 MAPK and modulation of Bcl-2 family.

Authors:  Hyun Soo Park; Hye Jin Hwang; Gi-Young Kim; Hee-Jae Cha; Wun-Jae Kim; Nam Deuk Kim; Young Hyun Yoo; Yung Hyun Choi
Journal:  Mar Drugs       Date:  2013-07-04       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.